GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Pre-Tax Income

ME Therapeutics Holding (XCNQ:METX) Pre-Tax Income : C$-6.93 Mil (TTM As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. ME Therapeutics Holding's pretax income for the three months ended in Feb. 2024 was C$-0.14 Mil. Its pretax income for the trailing twelve months (TTM) ended in Feb. 2024 was C$-6.93 Mil. ME Therapeutics Holding's pretax margin was %.

ME Therapeutics Holding Pre-Tax Income Historical Data

The historical data trend for ME Therapeutics Holding's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Pre-Tax Income Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Pre-Tax Income
-0.15 -6.52

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Pre-Tax Income Get a 7-Day Free Trial -0.06 -3.50 -2.95 -0.34 -0.14

Competitive Comparison of ME Therapeutics Holding's Pre-Tax Income

For the Biotechnology subindustry, ME Therapeutics Holding's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Pre-Tax Income falls into.


ME Therapeutics Holding Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

ME Therapeutics Holding's Pretax Income for the fiscal year that ended in Aug. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.977+-5.547+-0.007+0.011+0
=-6.52

ME Therapeutics Holding's Pretax Income for the quarter that ended in Feb. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.145+0+0+0.002+0
=-0.14

Pre-Tax Income for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-6.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding  (XCNQ:METX) Pre-Tax Income Explanation

ME Therapeutics Holding's Pretax Margin for the quarter that ended in Feb. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.143/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Pre-Tax Income
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines